LEVANT 2 Safety Registry
A Prospective, Multicenter, Registry of the Lutonix Drug Coated Balloon for Treatment of Femoropopliteal Arteries (LEVANT 2 Safety Registry)
Sponsor: C. R. Bard
Listed as NCT01790243, this NA trial focuses on Femoropopliteal Artery Occlusion and Femoropopliteal Stenosis and remains completed. Sponsored by C. R. Bard, it has been updated 10 times since 2011, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2023 — Jul 2024 [monthly]
Completed NA
-
Dec 2022 — Jan 2023 [monthly]
Completed NA
-
Jan 2021 — Dec 2022 [monthly]
Completed NA
▶ Show 5 earlier versions
-
Jul 2020 — Jan 2021 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Feb 2019 — Jul 2020 [monthly]
Active Not Recruiting NA
-
Jun 2018 — Feb 2019 [monthly]
Active Not Recruiting NA
-
Feb 2017 — Jun 2018 [monthly]
Active Not Recruiting NA
-
Jan 2017 — Feb 2017 [monthly]
Active Not Recruiting NA
First recorded
Jul 2011
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- C. R. Bard
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
- • Cincinnati, United States
- • Fremont, United States
- • Jackson, United States
- • New Braunfels, United States
- • New York, United States
- • Springfield, United States
- • Teaneck, United States
- • Wyoming, United States